Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$2.50
-2.92%
Mkt Cap $222.41M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+340.9%
Consensus $11.00 vs current $2.50
NASDAQ·Healthcare·Biotechnology
$2.50
-2.92%
Mkt Cap $222.41M
Buy
5
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+340.9%
Consensus $11.00 vs current $2.50